Results 31 to 40 of about 3,101,103 (310)
Clinical Case Reports, 2023 Key Clinical Message To investigate the blood supply characteristics and surgical significance of pituitary neuroendocrine tumors with vascular flow void signal in tumors.
Jiansheng Zhong, Jun Li, Shousen Wang
doaj +1 more source
BMC Medical Informatics and Decision Making, 2020 Background Accurately determining the softness level of pituitary tumors preoperatively by using their image textures can provide a basis for surgical options and prognosis.
Hong Zhu +3 more
doaj +1 more source
The Epigenomics of Pituitary Adenoma
Frontiers in Endocrinology, 2019 Background: The vast majority of pituitary tumors are benign and behave accordingly; however, a fraction are invasive and are more aggressive, with a very small fraction being frankly malignant.
Blake M. Hauser +4 more
doaj +1 more source
Best Achievements in Pituitary and Adrenal Diseases in 2020 [PDF]
Endocrinology and Metabolism, 2021 Significant progress in pituitary and adrenal diseases was made in 2020. This review presents major translational and clinical advances in research on pituitary and adrenal diseases, encompassing their epidemiology, pathogenesis, diagnosis, and clinical ...
Chang Ho Ahn, Jung Hee Kim
doaj +1 more source
Frontiers in Endocrinology, 2019 Although generally benign, pituitary tumors frequently show local invasiveness and resistance to pharmacological therapy. After the demonstration of the existence of pituitary gland stem cells, over the past decade, the presence of a stem cell ...
Giovanna Mantovani +10 more
doaj +1 more source
The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
Frontiers in Endocrinology, 2020 Most pituitary adenomas (PAs) are considered benign tumors, but approximately 0.2% can present metastasis and are classified as pituitary carcinomas (PCs).
Congxin Dai +3 more
doaj +1 more source
Circulating FK506 binding protein 51 mRNA expression in patients with pituitary adenomas
Heliyon, 2023 Background: FK506 binding protein 51 (FKBP5) is a co-chaperone regulator of the glucocorticoid receptor (GR). Recent studies have reported increased FKBP5 mRNA in the circulation from patients with Cushing disease (CD) which returned to comparable levels
Yingying Yang +10 more
doaj +1 more source
Pituitary Adenomas: From Diagnosis to Therapeutics
Biomedicines, 2021 Pituitary adenomas are tumors that arise in the anterior pituitary gland. They are the third most common cause of central nervous system (CNS) tumors among adults.
Samridhi Banskota, David C. Adamson
doaj +1 more source
Genetically engineered mouse models of pituitary tumors
Frontiers in Oncology, 2014 Animal models constitute valuable tools for investigating the pathogenesis of cancer as well as for preclinical testing of novel therapeutics approaches.
David A Cano +4 more
doaj +1 more source
BMC Endocrine Disorders, 2021 Background Pituitary adenomas are benign brain tumors that cause considerable morbidity and neurological symptoms. SOX9 as a regulatory transcriptional mediator affects normal and tumor cell growth with an undefined role in pituitary adenomas ...
Farzad Izak Shirian +8 more
doaj +1 more source